IDS, a mobile diagnostics platform backed by private‑equity firm HCAP, announced the purchase of Core Analytics Lab & Radiology. The deal adds on‑site imaging analysis and radiology reporting to IDS’s suite of point‑of‑care testing services. By integrating Core’s analytics engine, IDS can deliver results from blood draws, ultrasounds and other scans directly to clinicians’ tablets, shortening the diagnostic loop that traditionally required separate lab and imaging visits.

The acquisition reflects a broader wave of consolidation in the health‑tech sector, where companies seek end‑to‑end solutions to meet payer pressure for faster, cheaper care. Investors have been rewarding firms that combine sample collection, data analytics and tele‑medicine into a single workflow. Analysts expect IDS to leverage Core’s existing client base in hospitals and outpatient centers to accelerate market penetration.

Integration plans will focus on syncing electronic health‑record interfaces and expanding the mobile app’s reporting capabilities over the next twelve months. Regulatory clearance for the combined platform is slated for early 2027, and the firms anticipate cross‑selling opportunities that could boost revenue by double‑digits within three years.